DRUG-DRUG INTERACTIONS (DDIS) WITH PANGENOTYPIC DIRECT-ACTING ANTIVIRALS (DAAS) IN PATIENTS WITH HEPATITIS C; UNDERSTANDING THE POPULATIONS AT RISK AND REAL-WORLD CARE MANAGEMENT

被引：0
|
作者：
Curry, Michael P. [1 ]
Tsai, Naoky C. S. [2 ]
Bacon, Bruce R. [3 ]
Flamm, Steven L. [4 ]
Younossi, Zobair M. [5 ,6 ]
Milligan, Scott [7 ]
Wick, Nicole [7 ]
Afdhal, Nezam H. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Univ Hawaii, Honolulu, HI 96822 USA
[3] St Louis Univ, Sch Med, St Louis, MO USA
[4] Northwestern Univ, Div Hepatol, Feinberg Sch Med, Evanston, IL 60208 USA
[5] Inova Fairfax Hosp, Ctr Liver Dis, Falls Church, VA USA
[6] Inova Fairfax Hosp, Dept Med, Falls Church, VA USA
[7] Trio Hlth Analyt, La Jolla, CA USA
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1503
引用
收藏
页码：903A / 904A
页数：2
相关论文
共 50 条
  • [1] Drug-drug interactions (DDIs) with pangenotypic direct-acting antivirals (DAAs) in patients with hepatitis C; understanding the populations at risk and real-world care management
    Curry, Michael
    Tsai, Naoky
    Bacon, Bruce
    Flamm, Steven
    Younossi, Zobair
    Milligan, Scott
    Wick, Nicole
    Afdhal, Nezam
    JOURNAL OF HEPATOLOGY, 2020, 73 : S355 - S356
  • [2] Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: a retrospective observational study
    Curry, Michael P.
    Flamm, Steven L.
    Milligan, Scott
    Tsai, Naoky
    Wick, Nicole
    Younossi, Zobair
    Afdhal, Nezam H.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (09): : 1239 - 1248
  • [3] Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug-Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA)
    Fagiuoli, Stefano
    Toniutto, Pierluigi
    Coppola, Nicola
    Ancona, Domenica Daniela
    Andretta, Margherita
    Bartolini, Fausto
    Ferrante, Fulvio
    Lupi, Alessandro
    Palcic, Stefano
    Rizzi, Francesca Vittoria
    Re, Davide
    Nieto, Gema Alvarez
    Hernandez, Candido
    Frigerio, Francesca
    Perrone, Valentina
    Degli Esposti, Luca
    Mangia, Alessandra
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 57 - 65
  • [4] IMPACT OF POLYPHARMACY AND AGING ON THE RISK OF MULTIPLE DRUG-DRUG INTERACTIONS (DDIS) IN HCV PATIENTS TREATED WITH PANGENOTYPIC DIRECT-ACTING ANTIVIRALS (PDAA)
    Mangia, Alessandra
    Toniutto, Pierluigi
    Coppola, Nicola
    Ancona, Domenica Daniela
    Andretta, Margherita
    Bartolini, Fausto
    Ferrante, Fulvio
    Lupi, Alessandro
    Palcic, Stefano
    Rizzi, Francesca Vittoria
    Re, Davide
    Nieto, Gema Alvarez
    Hernandez, Candido
    Perrone, Valentina
    Degli Esposti, Luca
    Fagiuoli, Stefano
    HEPATOLOGY, 2021, 74 : 566A - 567A
  • [5] Frequency and impact of potential multiple drug-drug interactions (DDIs) associated with pangenotypic direct-acting antivirals in patients receiving opioid substitution therapy
    Umland, Tim
    Hintz, Andreas
    Niess, Gero
    Guendogdu, Mehtap
    Tacke, Frank
    JOURNAL OF HEPATOLOGY, 2021, 75 : S794 - S794
  • [6] Evaluation of drug-drug interactions of direct-acting antivirals in hepatitis c virus infected patients
    Margusino-Framinan, L.
    Castro-Iglesias, A.
    Gimenez-Arufe, V.
    Fernandez-Oliveira, C.
    Cid-Silva, P.
    Mena-De-Cea, A.
    Rodriguez-Osorio, I.
    Pernas-Souto, B.
    Yanez-Martinez, M. D.
    Pertega-Diaz, S.
    Sanclaudio-Luhia, A.
    Martin-Herranz, I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 311 - 311
  • [7] Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
    Hsu, Po-Yao
    Wei, Yu-Ju
    Lee, Jia-Jung
    Niu, Sheng-Wen
    Huang, Jiun-Chi
    Hsu, Cheng-Ting
    Jang, Tyng-Yuan
    Yeh, Ming-Lun
    Huang, Ching-, I
    Liang, Po-Cheng
    Lin, Yi-Hung
    Hsieh, Ming-Yen
    Hsieh, Meng-Hsuan
    Chen, Szu-Chia
    Dai, Chia-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Huang, Jee-Fu
    Chang, Jer-Ming
    Hwang, Shang-Jyh
    Chuang, Wan-Long
    Huang, Chung-Feng
    Chiu, Yi-Wen
    Yu, Ming-Lung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (01) : 186 - 196
  • [8] Drug-Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study
    Mangia, Alessandra
    Scaglione, Francesco
    Toniutto, Pierluigi
    Pirisi, Mario
    Coppola, Nicola
    Di Perri, Giovanni
    Nieto, Gema Alvarez
    Calabrese, Stefano
    Hernandez, Candido
    Perrone, Valentina
    Degli Esposti, Luca
    Fagiuoli, Stefano
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (13)
  • [9] RISK OF MULTIPLE DRUG INTERACTIONS POTENTIALLY LINKED TO SAFETY IN PATIENTS RECEIVING PANGENOTYPIC DIRECT-ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C
    Turnes, Juan
    Garcia-Herola, Antonio
    Morillo, Ramon
    Mendez, Marinela
    Rueda, Magdalena
    Hernandez, Candido
    Sicras-Mainar, Antoni
    GUT, 2022, 71 : A97 - A98
  • [10] Risk of multiple drug interactions potentially linked to safety in patients receiving pangenotypic direct-acting antivirals for the treatment of hepatitis C
    Turnes, J.
    Garcia-Herola, A.
    Morillo, R.
    Mendez, M.
    Rueda, M.
    Hernandez, C.
    Sicras-Mainar, A.
    Freismuth, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 42 - 42
12345